Carregant...
Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease (COVID-19), spreading from Wuhan to worldwide has been emerged since December 2019. Although scientists and researchers have been racing to develop specific therapeutic agents or vaccines against SARS-CoV-...
Guardat en:
| Publicat a: | Transfus Apher Sci |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Ltd.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7271837/ https://ncbi.nlm.nih.gov/pubmed/32593519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2020.102846 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|